Back to the Top
Dear Members,
Does anyone have information on the bioequivalence studies for
different insulin products from different suppliers? Is it necessary
to have both PK and PD assessments? For how long blood sampling is
required for short and intermediate acting insulin? What is the
acceptable CI for PD data (i.e., blood sugar reduction). What sample
size would be appropriate for biological studies like insulin?
Khalid Alkharfy
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)